17
Participants
Start Date
November 19, 2015
Primary Completion Date
July 22, 2017
Study Completion Date
January 11, 2019
Lenalidomide
Lenalidomide will be administered orally once daily for the first 21 days of every 28-day cycle. The starting dose will be 2 mg/kg/day with a maximum dose of 70 mg/day. Number of cycles: 12, or until evidence of progressive disease. Participants will also be discontinued if unresolved toxicities as described in the protocol occur, or if dose reductions are required and subject does not tolerate minimum dose level of 1mg/kg/day.
Columbia University Medical Center, New York
New York Medical College, Valhalla
Roswell Park Cancer Inst, Buffalo
University of Rochester Medical Center, Rochester
UPMC Childrens Hospital of Pittsburgh, Pittsburgh
Penn State Milton S Hershey Medical Center, Hershey
Alfred I Dupont Hospital For Children, Wilmington
Johns Hopkins University, Baltimore
Children's Hospital of The King's Daughters, Norfolk
University of North Carolina, Chapel Hill
Carolinas Healthcare System, Charleston
Greenville Health System, Greenville
Children's Healthcare of Atlanta, Atlanta
Nemours Children's Clinic, Jacksonville
All Children's Hospital, St. Petersburg
Golisano Children's Hospital of Southwest Florida, Fort Myers
Children's Hospital, Birmingham
Vanderbilt University Medical Center, Nashville
University of Mississippi Medical Center, Jackson
Kosair Children's Hospital, Louisville
Nationwide Children's Hospital, Columbus
Cincinnati Children's Hospital Medical Center, Cincinnati
Riley Hospital For Children at IU Health, Indianapolis
University of Michigan, Ann Arbor
Midwest Children's Cancer Center, Milwaukee
Children's Hospitals and Clinics of Minnesota, Minneapolis
University of Minnesota, Minneapolis
Advocate Chilldren's Hospital, Oak Lawn
Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
Washington University School of Medicine, St Louis
Children's Mercy Hospital, Kansas City
Children's Hospital New Orleans, New Orleans
Arkansas Children's Hospital, Little Rock
University of Texas Southwestern Medical Center, Dallas
Texas Children's Cancer Center, Houston
Methodist Hospital, San Antonio
Dell Children's Medical Center of Central Texas, Austin
Colorado Children's Hospital, Aurora
Primary Children's Medical Center, Salt Lake City
Phoenix Childrens Hospital, Phoenix
Children's Specialty Center of Nevada, Las Vegas
Children's Hospital of Los Angeles, Los Angeles
Southern California Permanente Medical Group, Los Angeles
Miller Children's Hospital, Long Beach
Loma Linda University, San Bernardino
Children's Hospital of Orange County, Orange
Valley Children's Hospital, Madera
UCSF Children's Hospital, San Francisco
Lucile Salter Packard Children's Hospital at Stanford, Palo Alto
Legacy Emanuel Hospital and Health Center, Portland
Seattle Children's Hospital, Seattle
Connecticut Children's Medical Center, Hartford
Children's Hospital National Medical Center, Washington D.C.
Hackensack University Medical Center, Hackensack
Morristown Memorial Hosp, Morristown
Cancer Institute of New Jersey, New Brunswick
Alberta Childrens Hospital, Calgary
British Columbia Children's Hospital, Vancouver
IWK Health Center, Halifax
Childrens Hospital of Eastern Ontario, Ottawa
McGill University Health Center, Montreal
Hospital For Sick Children, Torento
Lead Sponsor
Celgene
INDUSTRY